22-24 October, 2018
Frankfurt, Germany

The Industry Definitive Forum
for Actionable Insights

Although 2018 marks over 150 companies and 190 pipeline products in development for NASH; there remains no approved treatment for NASH and critical gaps in our understanding of how to efficaciously deliver one.

The NASH Summit Europe is the only niche, focused conference uniting the industry’s front-runners advancing NASH drug development, to analyse challenges and the latest data through a tighter lens.

For three packed days, hear directive discussions, actionable insights and global perspectives on topics including commercialization and regulatory hurdles, to apply to your own NASH pipeline decisions.

  • Understand Pfizer’s approach to unexpected safety findings
  • Hear the latest from Genfit on their in vitro diagnostic test
  • Map out the emerging therapeutic market with case studies from NorthSea Therapeutics, Poxel Pharmaceuticals and Can-Fite Biopharma

Download the full event guide here and be part of the face-to-face conversations pivotal to the field right now.

 

“Excellent opportunity to catch up with the field, hear other industry speakers present their work”
Genentech, 2nd NASH Summit, Boston

"Great event exceptional networking opportunities. High quality of presentations. Very efficient way to spend my time."
Synexus, 2nd NASH Summit, Boston

 
Media Partner